PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-12-12 (1)

Date Title Company
12-Dec-2022 Genmab Showcases Data From Robust Development Program Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients Across a Broad Range of B-Cell Lymphomas at the 64th Annual ASH Meeting Businesswire